Clinical trial Recruiting at 2 sites Observational Ages 18 to 80 Women only

Axillary Web Syndrome after Breast Cancer Surgery: Incidence, Risk Factors, and Outcomes

Official title: A Prospective Multicenter Cohort Study on the Incidence, Risk Factors, and Postoperative Functional Outcomes of Axillary Web Syndrome After Breast Cancer Surgery

Run by Antalya City Hospital · NCT07780240 · Data updated 2026-11-12

This study tests how often AWS occurs after breast cancer surgery and what factors make it more likely, using a forward-looking approach in women undergoing SLNB or ALND.

More Breast Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexWomen only
Enrollment250 (estimated)
SponsorAntalya City Hospital
Academic / other
Locations2 sites (Istanbul, BAGCILAR and 1 other locations)
StatusRecruiting
StartedMay 1, 2026
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07780240 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with breast cancer undergoing SLNB or ALND who can consent and are able to comply with follow-up.

Probably not a fit

Patients who do not develop AWS or who have no meaningful changes in shoulder function may not benefit from any intervention in this observational design.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter observational cohort study of women undergoing breast cancer surgery with axillary staging. Participants are followed before surgery and at 2, 4, and 8 weeks, and at 3 and 6 months after surgery to document the appearance, course, and potential factors related to axillary web syndrome. Data are collected using standardized assessments to determine incidence, timing, clinical features, and associations with lymphedema and functional outcomes. There is no treatment assignment or control group within the study; comparisons are made within the cohort between those who develop AWS and those who do not.

Why it matters

Potential benefit: If successful, the study could clarify when AWS tends to occur and which patients are at higher risk, informing monitoring and early management.

How similar studies have gone: Previous data are mainly retrospective; this prospective approach aims to provide clearer incidence and risk factors, with some prior studies suggesting AWS is relatively common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Diagnosis of breast cancer with planned surgical treatment
* Axillary staging performed by sentinel lymph node biopsy or axillary lymph node dissection
* Written informed consent provided

Exclusion Criteria:

* Preoperative restriction of shoulder range of motion
* History of neuromuscular disease affecting the upper extremity
* Metastatic disease
* Anticipated inability to comply with the follow-up protocol

Where it's running

  • Bagcilar Training and Research Hospital
    Istanbul, Bagcilar, Turkey (Türkiye)
    Recruiting
  • Antalya City Hospital
    Antalya, Kepez, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.